These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18304854)

  • 21. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
    Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and complications of patients with type 2 diabetes attending an urban hospital in Bangladesh.
    Islam SM; Alam DS; Wahiduzzaman M; Niessen LW; Froeschl G; Ferrari U; Seissler J; Rouf HM; Lechner A
    Diabetes Metab Syndr; 2015; 9(1):7-13. PubMed ID: 25450814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-insulin treated diabetes: relationship between disease management and quality of care. The Entred study, 2001].
    Fagot-Campagna A; Romon I; Poutignat N; Bloch J;
    Rev Prat; 2007 Dec; 57(20):2209-16. PubMed ID: 18320738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A nationwide retrospective analysis on chronic diabetic complications and related macrovascular diseases of in-patients with diabetes during 1991-2000].
    ;
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):447-51. PubMed ID: 12905762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current management of type 2 diabetes in France].
    Jaffiol C
    Bull Acad Natl Med; 2009 Oct; 193(7):1645-61. PubMed ID: 20669642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focussed section "Effect of oral antidiabetic drugs on micro- and macrovascular complications in patients with diabetes mellitus--update 2008".
    Marx N
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):205-6. PubMed ID: 18521728
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk.
    Leong A; Berkowitz SA; Triant VA; Porneala B; He W; Atlas SJ; Wexler DJ; Meigs JB
    J Clin Endocrinol Metab; 2016 Feb; 101(2):659-68. PubMed ID: 26672635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes care and complications in primary care in the Tshwane district of South Africa.
    Webb EM; Rheeder P; Van Zyl DG
    Prim Care Diabetes; 2015 Apr; 9(2):147-54. PubMed ID: 24933340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.
    Hermans MP; Ahn SA; Rousseau MF
    Cardiovasc Diabetol; 2010 Dec; 9():88. PubMed ID: 21156040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.
    Tseng LN; Tseng YH; Jiang YD; Chang CH; Chung CH; Lin BJ; Chuang LM; Tai TY; Sheu WH
    J Formos Med Assoc; 2012 Nov; 111(11):625-36. PubMed ID: 23217598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sugar and stroke: cerebrovascular disease and blood glucose control.
    Quinn TJ; Dawson J; Walters MR
    Cardiovasc Ther; 2011 Dec; 29(6):e31-42. PubMed ID: 20491782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of introducing HbA1c into the diagnostic criteria on prevalence and cardiovascular risk profiles of individuals with newly diagnosed diabetes in Japan: the Toranomon Hospital Health Management Center Study 2 (TOPICS 2).
    Heianza Y; Hara S; Arase Y; Saito K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Okubo M; Yamada N; Kosaka K; Sone H
    Diabetes Res Clin Pract; 2012 Feb; 95(2):283-90. PubMed ID: 22104263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus.
    Wang S; Hou X; Liu Y; Lu H; Wei L; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Oct; 12():146. PubMed ID: 24112518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study.
    Mohan V; Shah S; Saboo B
    J Assoc Physicians India; 2013 Jan; 61(1 Suppl):12-5. PubMed ID: 24482981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes.
    Littmann K; Wodaje T; Alvarsson M; Bottai M; Eriksson M; Parini P; Brinck J
    Diabetes Care; 2020 Aug; 43(8):1851-1858. PubMed ID: 31862789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
    Bjornstad P; Maahs DM; Rewers M; Johnson RJ; Snell-Bergeon JK
    J Diabetes Complications; 2014; 28(6):762-6. PubMed ID: 25270733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose supply and insulin demand dynamics of antidiabetic agents.
    Monte SV; Schentag JJ; Adelman MH; Paladino JA
    J Diabetes Sci Technol; 2010 Mar; 4(2):365-81. PubMed ID: 20307399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.